DRUG RECALLS: MAY 2010
MAY 2010: BENADRYL EXTRA STRENGTH ITCHING STOP GEL RECALLED BECAUSE OF CHANGES TO THE GRAPHICS AND INFORMATION DISPLAYED IN FRONT OF THE PRODUCT CONTAINER TO REDUCE THE RISK OF SERIOUS SIDE EFFECTS FROM SWALLOWING THE TOPICAL GEL. REPORTS WERE MADE THAT PEOPLE INGESTED THE GEL RATHER THAN USING IT TOPICALLY.
MAY 2010: LOTS OF METRONIDAZOLE INJECTION USP 500MG/100ML RECALLED DUE TO THE DISCOVERY OF NON-STERILITY THAT COULD LEAD FATAL
MAY 2010: ULTRAM (TRAMADOL HCL) PAIN KILLER DRUG RECALLED DUE TO LABEL CHANGE WARNINGS ABOUT THE RISK OF SUICIDE FOR PATIENTS WHO ARE ADDICTION-PRONE, TAKING TRANQUILIZERS OR ANTI-DEPRESSANTS DRUGS, ALSO WARNS OF THE RISK OF OVERDOSING
MAY 2010: ORLISTAT (ALLI/XENICAL) RECALLED DUE TO NEW REVISED LABEL TO INCLUDE SAFETY INFO ABOUT CASES OF SEVERE LIVER INJURY THAT HAS BEEN REPORTED WITH THE USE OF THIS DRUG, ALSO THIS LABEL GOES TO THE OTC DRUG ALLI.
MAY 2010: PROTON PUMP INHIBITORS (REDUCE AMOUNT OF ACID IN STOMACH) RECALLED DUE TO CLASS LABELING CHANGE TO INCLUDE IN SAFETY INFORMATION THAT THERE ARE RISKS OF FRACTURES IN THE HIP, WRIST & SPINE WHEN USING THESE TYPES OF DRUGS.
MAY 2010: PEDIACARE CHILDREN'S PRODUCTS
- (PEDICARE MULTISYMPTOM COLD) 4OZ
- (PEDIACARE LONG ACTING COUGH) 4OZ
- (PEDIACARE DECONGESTANT) 4OZ
- (PEDIACARE ALLERGY & COLD) 4OZ
RECALLED DUE TO A RECENT FDA INSPECTION THAT FOUND SERIOUS PROBLEMS IN MEETING FDA REQUIREMENTS
MAY 2010: INTRAVENOUS MEDICATIONS METRONIDAZOLE, CIPROFLOXACIN, AND ONDANSETRON RECALLED DUE TO CONTAMINATION
MAY 2010: ARROW BRAND MEDICATED OIL AND EMBROCATION PRODUCT IS CONSIDERED TOXIC
